9776 related articles for article (PubMed ID: 1607409)
1. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects.
Krüger S; Garbe C; Büttner P; Stadler R; Guggenmoos-Holzmann I; Orfanos CE
J Am Acad Dermatol; 1992 Jun; 26(6):920-6. PubMed ID: 1607409
[TBL] [Abstract][Full Text] [Related]
2. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
[TBL] [Abstract][Full Text] [Related]
3. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry.
Rieger E; Soyer HP; Garbe C; Büttner P; Kofler R; Weiss J; Stocker U; Krüger S; Roser M; Weckbecker J
Int J Cancer; 1995 Aug; 62(4):393-7. PubMed ID: 7635564
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
5. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
6. Body-site distribution of melanocytic nevi in young Australian children.
Harrison SL; Buettner PG; MacLennan R
Arch Dermatol; 1999 Jan; 135(1):47-52. PubMed ID: 9923780
[TBL] [Abstract][Full Text] [Related]
7. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma.
Randi G; Naldi L; Gallus S; Di Landro A; La Vecchia C;
J Invest Dermatol; 2006 Sep; 126(9):2106-10. PubMed ID: 16645584
[TBL] [Abstract][Full Text] [Related]
8. [The sun and malignant melanoma].
Garbe C
Hautarzt; 1992 May; 43(5):251-7. PubMed ID: 1612913
[TBL] [Abstract][Full Text] [Related]
9. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy).
Naldi L; Altieri A; Imberti GL; Gallus S; Bosetti C; La Vecchia C;
Cancer Causes Control; 2005 Oct; 16(8):893-9. PubMed ID: 16132799
[TBL] [Abstract][Full Text] [Related]
10. Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: Nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma.
Rokuhara S; Saida T; Oguchi M; Matsumoto K; Murase S; Oguchi S
J Am Acad Dermatol; 2004 May; 50(5):695-700. PubMed ID: 15097952
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in the anatomical distribution of melanocytic nevi in Canadian Hutterite children.
Kwan TY; Belke TW; Enta T
J Cutan Med Surg; 2000 Apr; 4(2):58-62. PubMed ID: 11179925
[TBL] [Abstract][Full Text] [Related]
12. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women.
Weinstock MA; Colditz GA; Willett WC; Stampfer MJ; Bronstein BR; Mihm MC; Speizer FE
J Natl Cancer Inst; 1989 Jun; 81(12):948-52. PubMed ID: 2733040
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study.
Carli P; Massi D; Santucci M; Biggeri A; Giannotti B
J Am Acad Dermatol; 1999 Apr; 40(4):549-57. PubMed ID: 10188672
[TBL] [Abstract][Full Text] [Related]
14. Melanocytic naevi, melanoma and sun exposure.
Augustsson A
Acta Derm Venereol Suppl (Stockh); 1991; 166():1-34. PubMed ID: 1814137
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group.
Autier P; Doré JF; Lejeune F; Koelmel KF; Geffeler O; Hille P; Cesarini JP; Lienard D; Liabeuf A; Joarlette M
Int J Cancer; 1994 Sep; 58(6):809-13. PubMed ID: 7927872
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma in Italy: risks associated with common and clinically atypical melanocytic nevi.
Carli P; Biggeri A; Giannotti B
J Am Acad Dermatol; 1995 May; 32(5 Pt 1):734-9. PubMed ID: 7722017
[TBL] [Abstract][Full Text] [Related]
17. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study.
Stierner U; Augustsson A; Rosdahl I; Suurküla M
Melanoma Res; 1992; 1(5-6):367-75. PubMed ID: 1422192
[TBL] [Abstract][Full Text] [Related]
18. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Büttner P; Weiss J; Soyer HP; Stocker U; Krüger S; Roser M; Weckbecker J; Panizzon R; Bahmer F
J Invest Dermatol; 1994 May; 102(5):700-5. PubMed ID: 8176251
[TBL] [Abstract][Full Text] [Related]
19. Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis.
Olsen CM; Zens MS; Stukel TA; Sacerdote C; Chang YM; Armstrong BK; Bataille V; Berwick M; Elwood JM; Holly EA; Kirkpatrick C; Mack T; Bishop JN; Østerlind A; Swerdlow AJ; Zanetti R; Green AC; Karagas MR; Whiteman DC
Int J Cancer; 2009 Feb; 124(4):937-44. PubMed ID: 19035450
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]